Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2569.4000 -10.10 (-0.39%)
NSE Apr 23, 2025 09:29 AM
Volume: 15,099
 

logo
Mankind Pharma Ltd.
23 Aug 2024, 12:00AM
2569.40
-0.39%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors increased from 624 to 640 in Mar 2025 qtr.
More from Mankind Pharma Ltd.
Recommended